These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes. Larsen HS; Russell RG; Rouse BT Infect Immun; 1983 Jul; 41(1):197-204. PubMed ID: 6305838 [TBL] [Abstract][Full Text] [Related]
26. Innate and acquired immunity to herpes simplex virus type 1. Halford WP; Veress LA; Gebhardt BM; Carr DJ Virology; 1997 Sep; 236(2):328-37. PubMed ID: 9325240 [TBL] [Abstract][Full Text] [Related]
27. An adoptive cell transfer system for the evaluation of immunity to Herpes simplex virus in mice. Favila L; Howes EL; Taylor WA; Mitchison NA Clin Exp Immunol; 1982 May; 48(2):307-14. PubMed ID: 7105488 [TBL] [Abstract][Full Text] [Related]
28. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge. Frye TD; Chiou HC; Hull BE; Bigley NJ Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314 [TBL] [Abstract][Full Text] [Related]
29. Induction of cell-mediated immunity in herpes simplex virus keratitis. Kinetics of lymphocyte transformation and the effect of antiviral antibody. Meyers-Elliott RH; Chitjian PA Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):920-9. PubMed ID: 6250986 [TBL] [Abstract][Full Text] [Related]
30. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice. Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102 [TBL] [Abstract][Full Text] [Related]
31. Treatment of mice with anti-CD86 mAb reduces CD8+ T cell-mediated CTL activity and enhances ocular viral replication in HSV-1-infected mice. Osorio Y; Cai S; Ghiasi H Ocul Immunol Inflamm; 2005; 13(2-3):159-67. PubMed ID: 16019675 [TBL] [Abstract][Full Text] [Related]
32. Enhancement of passive antilisterial immunity and change of Lyt phenotype following in vitro stimulation of murine lymphoid cells from immune donors. Barry RA; Hinrichs DJ Clin Invest Med; 1984; 7(4):303-9. PubMed ID: 6442653 [TBL] [Abstract][Full Text] [Related]
33. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530 [TBL] [Abstract][Full Text] [Related]
34. Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition. Gangappa S; Babu JS; Thomas J; Daheshia M; Rouse BT J Immunol; 1998 Oct; 161(8):4289-300. PubMed ID: 9780205 [TBL] [Abstract][Full Text] [Related]
36. Regulatory role of T lymphocytes and NK cells in tumor allograft development. Sobotková E; Nouza K Neoplasma; 1993; 40(2):75-80. PubMed ID: 8350958 [TBL] [Abstract][Full Text] [Related]
37. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines. Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288 [TBL] [Abstract][Full Text] [Related]
38. Effects of CXCR3 signaling on development of fatal encephalitis and corneal and periocular skin disease in HSV-infected mice are mouse-strain dependent. Lundberg P; Openshaw H; Wang M; Yang HJ; Cantin E Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4162-70. PubMed ID: 17724202 [TBL] [Abstract][Full Text] [Related]